BioAtla BCAB
NASDAQ BCAB
$3.18 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:59 PM EDT

BioAtla (BCAB) Property, Plant & Equipment (Net) (2020 - 2025)

BioAtla (BCAB) Property, Plant & Equipment (Net) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 BioAtla 5.41 Mn 5.41 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 120,000.00
Dec 31, 2025 120,000.00
Sep 30, 2025 324,000.00
Sep 30, 2025 324,000.00
Jun 30, 2025 380,000.00
Jun 30, 2025 380,000.00
Mar 31, 2025 495,000.00
Mar 31, 2025 495,000.00
Dec 31, 2024 678,000.00
Dec 31, 2024 678,000.00
Sep 30, 2024 906,000.00
Sep 30, 2024 906,000.00
Jun 30, 2024 1.13 Mn
Jun 30, 2024 1.13 Mn
Mar 31, 2024 1.36 Mn
Mar 31, 2024 1.36 Mn
Dec 31, 2023 1.60 Mn
Dec 31, 2023 1.60 Mn
Sep 30, 2023 1.97 Mn
Sep 30, 2023 1.97 Mn